MAKO MEDICAL LABORATORIES LLC

MAKO MEDICAL LABORATORIES LLC specializes in advanced genetic testing and molecular diagnostics, with demonstrated expertise in COVID-19 genetic coding and genomic analysis. The company delivers high-complexity laboratory services centered on nucleic acid sequencing, variant identification, and bioinformatics-driven data interpretation, supporting public health surveillance and infectious disease response. Their technical capabilities include next-generation sequencing platforms, real-time PCR validation, and compliance with CLIA and CAP standards for clinical laboratory operations. While not certified under federal small business programs, the firm operates with precision in high-stakes diagnostic environments, emphasizing accuracy, turnaround efficiency, and data integrity in genetic reporting. The contractor has delivered services to the Department of Health and Human Services, primarily supporting pandemic response initiatives through genomic sequencing of SARS-CoV-2 specimens. This engagement reflects a focused relationship with HHS agencies engaged in infectious disease monitoring, where MAKO provides critical laboratory intelligence to inform public health decision-making. The nature of the work suggests alignment with CDC and ASPR objectives, particularly in pathogen tracking and genomic epidemiology. The primary NAICS code 541380—Testing Laboratories and Services—indicates a market positioning as a specialized diagnostic provider within the clinical and public health testing sector. MAKO’s focus on genetic coding places it in the niche of molecular diagnostics, serving government-led initiatives requiring rapid, scalable genomic analysis. This vertical specialization distinguishes the firm from general clinical labs, targeting high-complexity, sequence-based testing needs. Headquartered in Raleigh, North Carolina, MAKO MEDICAL LABORATORIES LLC is a small, privately held entity with no federal certifications on record. Its geographic presence is centered in the Southeast, with operational capacity aligned to support federal health security missions through localized, high-throughput laboratory infrastructure.